Hartline Investment Corp Novo Cure LTD Transaction History

Hartline Investment Corp

$795 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$40.29 - $82.51 $460,514 - $943,089	11,430 Added 3.75%	316,331 $13.1 Million
Q1 2023 May 08, 2023	BUY	$56.44 - $118.81 $23,648 - $49,781	419 Added 0.14%	304,901 $18.3 Million
Q4 2022 Feb 06, 2023	BUY	$63.98 - $85.37 $19.5 Million - $26 Million	304,482 New	304,482 $22.3 Million
Q2 2022 Aug 11, 2022	BUY	$56.6 - $89.9 $1.87 Million - $2.97 Million	32,997 Added 10.92%	335,191 $23.3 Million
Q1 2022 May 10, 2022	SELL	$60.15 - $84.52 $957,287 - $1.35 Million	-15,915 Reduced 5.0%	302,194 $25 Million
Q4 2021 Feb 08, 2022	BUY	$75.08 - $121.99 $899,908 - $1.46 Million	11,986 Added 3.92%	318,109 $23.9 Million
Q3 2021 Nov 09, 2021	BUY	$116.17 - $194.55 $456,431 - $764,386	3,929 Added 1.3%	306,123 $35.6 Million
Q2 2021 Aug 10, 2021	SELL	$130.4 - $225.58 $3.08 Million - $5.33 Million	-23,612 Reduced 7.25%	302,194 $67 Million
Q1 2021 May 12, 2021	SELL	$124.11 - $190.17 $1.16 Million - $1.78 Million	-9,385 Reduced 2.8%	325,806 $43.1 Million
Q4 2020 Feb 09, 2021	SELL	$112.16 - $174.14 $44,303 - $68,785	-395 Reduced 0.12%	335,191 $58 Million
Q3 2020 Nov 10, 2020	SELL	$58.05 - $111.31 $59,849 - $114,760	-1,031 Reduced 0.31%	335,586 $37.4 Million
Q2 2020 Aug 12, 2020	BUY	$57.2 - $74.41 $369,168 - $480,242	6,454 Added 1.95%	336,617 $20 Million
Q1 2020 May 11, 2020	SELL	$57.05 - $95.75 $29,038 - $48,736	-509 Reduced 0.15%	330,163 $22.2 Million
Q4 2019 Feb 10, 2020	BUY	$68.3 - $93.8 $14,752 - $20,260	216 Added 0.07%	330,672 $27.9 Million
Q3 2019 Nov 13, 2019	SELL	$61.86 - $97.8 $317,279 - $501,616	-5,129 Reduced 1.53%	330,456 $24.7 Million
Q2 2019 Aug 08, 2019	SELL	$42.22 - $63.23 $290,051 - $434,390	-6,870 Reduced 2.01%	335,585 $21.2 Million
Q1 2019 May 10, 2019	SELL	$31.96 - $56.12 $2 Million - $3.51 Million	-62,611 Reduced 15.46%	342,455 $16.5 Million
Q4 2018 Feb 13, 2019	SELL	$28.72 - $52.63 $130,388 - $238,940	-4,540 Reduced 1.11%	405,066 $13.6 Million
Q3 2018 Nov 09, 2018	SELL	$32.0 - $52.4 $170,336 - $278,925	-5,323 Reduced 1.28%	409,606 $21.5 Million
Q2 2018 Aug 10, 2018	BUY	$19.85 - $32.0 $215,908 - $348,064	10,877 Added 2.69%	414,929 $13 Million
Q1 2018 May 14, 2018	BUY	$19.3 - $23.65 $262,074 - $321,143	13,579 Added 3.48%	404,052 $8.81 Million
Q4 2017 Feb 13, 2018	BUY	$16.3 - $21.9 $363,587 - $488,501	22,306 Added 6.06%	390,473 $7.89 Million
Q3 2017 Nov 20, 2017	BUY	$18.05 - $21.75 $6.65 Million - $8.01 Million	368,167	368,167 $7.31 Million

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$374 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$365 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$244 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$133 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$93.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartline Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hartline Investment Corp with notifications on news.

Account